A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Discover what Hollywood stars are saying about Ozempic, the weight-loss drug. From shocking side effects to personal ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Health Secretary Robert F. Kennedy Jr. on Wednesday labeled the increasing rates of autism in children an epidemic and said ...

A HEALTHCARE worker has insisted Mounjaro has been “life-changing” after she shed five stone in seven months. Connie Bulloch, ...

Middle-aged folks and seniors whose weed use lands them in the hospital are at higher risk for developing dementia within a ...

As an affordability crisis grows in pricey New England, the rising cost of prescription drugs is squeezing patients, health ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Eli Lilly’s new oral weight loss pill, orforglipron, successfully passed late-stage trials, showing positive results for ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

A CONDITION affecting 10 million Brits has been detected as a new risk factor for strokes in young people. Strokes – where ...